# Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers

> **NCT05105243** · PHASE1 · COMPLETED · sponsor: **Cerevance** · enrollment: 64 (actual)

## Conditions studied

- Safety Issues
- Tolerance

## Interventions

- **DRUG:** CVN766

## Key facts

- **NCT ID:** NCT05105243
- **Lead sponsor:** Cerevance
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-17
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-11-21
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105243, "Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05105243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*